These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17037967)

  • 1. Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations.
    Mulder DJ; Water TV; Lutgers HL; Graaff R; Gans RO; Zijlstra F; Smit AJ
    Diabetes Technol Ther; 2006 Oct; 8(5):523-35. PubMed ID: 17037967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.
    Meerwaldt R; Hartog JW; Graaff R; Huisman RJ; Links TP; den Hollander NC; Thorpe SR; Baynes JW; Navis G; Gans RO; Smit AJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3687-93. PubMed ID: 16280473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin autofluorescence is associated with carotid intima-media thickness, diabetic microangiopathy, and long-lasting metabolic control in type 1 diabetic patients. Results from Poznan Prospective Study.
    Araszkiewicz A; Naskret D; Zozulinska-Ziolkiewicz D; Pilacinski S; Uruska A; Grzelka A; Wegner M; Wierusz-Wysocka B
    Microvasc Res; 2015 Mar; 98():62-7. PubMed ID: 25582078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased accumulation of skin advanced glycation end products is associated with microvascular complications in type 1 diabetes.
    Araszkiewicz A; Naskret D; Niedzwiecki P; Samborski P; Wierusz-Wysocka B; Zozulinska-Ziolkiewicz D
    Diabetes Technol Ther; 2011 Aug; 13(8):837-42. PubMed ID: 21568748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications.
    Gerrits EG; Lutgers HL; Kleefstra N; Graaff R; Groenier KH; Smit AJ; Gans RO; Bilo HJ
    Diabetes Care; 2008 Mar; 31(3):517-21. PubMed ID: 18039805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of skin autofluorescence as a marker of advanced glycation end product accumulation in type 1 diabetes.
    Samborski P; Naskręt D; Araszkiewicz A; Niedźwiecki P; Zozulińska-Ziółkiewicz D; Wierusz-Wysocka B
    Pol Arch Med Wewn; 2011 Mar; 121(3):67-72. PubMed ID: 21430607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney disease.
    Smit AJ; Gerrits EG
    Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):527-33. PubMed ID: 20844429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence: A novel marker of vascular complications in high-risk patients for cardiovascular disease.
    Yamagishi S; Fukami K; Matsui T
    Int J Cardiol; 2015 Apr; 185():263-8. PubMed ID: 25814214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy.
    Chabroux S; Canouï-Poitrine F; Reffet S; Mills-Joncour G; Morelon E; Colin C; Thivolet C
    Diabetes Metab; 2010 Apr; 36(2):152-7. PubMed ID: 20137994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive Measurement of Skin Autofluorescence as a Beneficial Surrogate Marker for Atherosclerosis in Patients with Type 2 Diabetes.
    Temma J; Matsuhisa M; Horie T; Kuroda A; Mori H; Tamaki M; Endo I; Aihara K; Abe M; Matsumoto T
    J Med Invest; 2015; 62(3-4):126-9. PubMed ID: 26399335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verification of skin autofluorescence values by mass spectrometry in adolescents with type 1 diabetes: brief report.
    Mácsai E; Takáts Z; Derzbach L; Körner A; Vásárhelyi B
    Diabetes Technol Ther; 2013 Mar; 15(3):269-72. PubMed ID: 23343332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple non-invasive assessment of advanced glycation endproduct accumulation.
    Meerwaldt R; Graaff R; Oomen PHN; Links TP; Jager JJ; Alderson NL; Thorpe SR; Baynes JW; Gans ROB; Smit AJ
    Diabetologia; 2004 Jul; 47(7):1324-1330. PubMed ID: 15243705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin autofluorescence is elevated in neovascular age-related macular degeneration.
    Mulder DJ; Bieze M; Graaff R; Smit AJ; Hooymans JM
    Br J Ophthalmol; 2010 May; 94(5):622-5. PubMed ID: 19726430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin autofluorescence is associated with vascular complications in patients with type 2 diabetes.
    Osawa S; Katakami N; Sato I; Ninomiya H; Omori K; Yamamoto Y; Takahara M; Miyashita K; Sakamoto F; Kawamori D; Matsuoka T; Shimomura I
    J Diabetes Complications; 2018 Sep; 32(9):839-844. PubMed ID: 30099985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin Autofluorescence is Associated with Early-stage Atherosclerosis in Patients with Type 1 Diabetes.
    Osawa S; Katakami N; Kuroda A; Takahara M; Sakamoto F; Kawamori D; Matsuoka T; Matsuhisa M; Shimomura I
    J Atheroscler Thromb; 2017 Mar; 24(3):312-326. PubMed ID: 27592627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products.
    Mulder DJ; van Haelst PL; Gross S; de Leeuw K; Bijzet J; Graaff R; Gans RO; Zijlstra F; Smit AJ
    Atherosclerosis; 2008 Mar; 197(1):217-23. PubMed ID: 17499742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin autofluorescence is inversely related to HDL anti-oxidative capacity in type 2 diabetes mellitus.
    Mulder DJ; de Boer JF; Graaff R; de Vries R; Annema W; Lefrandt JD; Smit AJ; Tietge UJ; Dullaart RP
    Atherosclerosis; 2011 Sep; 218(1):102-6. PubMed ID: 21665206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation end products in renal failure: an overview.
    Noordzij MJ; Lefrandt JD; Smit AJ
    J Ren Care; 2008 Dec; 34(4):207-12. PubMed ID: 19090900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes.
    Lutgers HL; Graaff R; Links TP; Ubink-Veltmaat LJ; Bilo HJ; Gans RO; Smit AJ
    Diabetes Care; 2006 Dec; 29(12):2654-9. PubMed ID: 17130200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus.
    de Leeuw K; Graaff R; de Vries R; Dullaart RP; Smit AJ; Kallenberg CG; Bijl M
    Rheumatology (Oxford); 2007 Oct; 46(10):1551-6. PubMed ID: 17848401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.